Literature DB >> 6708533

Variations in the levels of secretory component in human uterine fluid during the menstrual cycle.

D A Sullivan, G S Richardson, D T MacLaughlin, C R Wira.   

Abstract

To determine whether variations in the level of secretory component (SC) occur during the menstrual cycle, we compared the amounts of SC in human uterine secretions during the proliferative, secretory, and menstrual phases. Uterine washes were obtained from women (ages: 18-49) with histologically normal endometria by lavage with Gravlee jet wash device using isotonic glycine. SC was measured by a radioimmunoassay which recognizes primarily free SC. Levels of uterine luminal SC, when expressed as the percentage of total wash protein, were highest during the secretory phase, significantly reduced during the proliferative phase and lowest during menstruation. The mean protein concentration in uterine fluids did not vary significantly during the menstrual cycle. Total amounts of SC were also greatest during the secretory phase, averaging two times higher than SC levels in proliferative samples. These results demonstrate that fluctuations do occur in the SC content of human uterine secretions during the menstrual cycle and suggest that hormones play an important role in the secretory immune system of the human uterus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6708533     DOI: 10.1016/0022-4731(84)90263-2

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  13 in total

1.  Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens.

Authors:  Daniel O Ochiel; John V Fahey; Mimi Ghosh; Severina N Haddad; Charles R Wira
Journal:  Curr Womens Health Rev       Date:  2008-05

2.  Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens.

Authors:  Charles R Wira; John V Fahey; Mimi Ghosh; Mickey V Patel; Danica K Hickey; Daniel O Ochiel
Journal:  Am J Reprod Immunol       Date:  2010-03-29       Impact factor: 3.886

Review 3.  The role of sex hormones in immune protection of the female reproductive tract.

Authors:  Charles R Wira; Marta Rodriguez-Garcia; Mickey V Patel
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

4.  Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina.

Authors:  C R Wira; R M Rossoll
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

Review 5.  Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections.

Authors:  D K Hickey; M V Patel; J V Fahey; C R Wira
Journal:  J Reprod Immunol       Date:  2011-02-26       Impact factor: 4.054

6.  Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract.

Authors:  A L Howell; R D Edkins; S E Rier; G R Yeaman; J E Stern; M W Fanger; C R Wira
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Estradiol regulation of constitutive and keratinocyte growth factor-induced CCL20 and CXCL1 secretion by mouse uterine epithelial cells.

Authors:  Severina N Haddad; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2014-05-08       Impact factor: 3.886

Review 8.  Research gaps in defining the biological link between HIV risk and hormonal contraception.

Authors:  Kerry Murphy; Susan C Irvin; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2014-02-19       Impact factor: 3.886

Review 9.  A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.

Authors:  Charles R Wira; John V Fahey
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

10.  Secretory component in breast cancer. Analysis of the levels in primary and metastatic disease.

Authors:  J E Stern; B J Underdown; R W Crichlow; C R Wira
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.